Besides, the pharmacological inhibition of cyclin dependent kinase 7 (CDK7), bromodomain-containing protein 4 (BRD4) and histone deacetylases (HDACs), has been applied in esophageal carcinoma treatment (13). Here, BRD4 is linked to carcinoma of esophagus.